Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest of Avid Bioservices, Inc. from 30 Apr 2016 to 31 Oct 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.
Summary
Avid Bioservices, Inc. quarterly and annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest in USD history and change rate from 30 Apr 2016 to 31 Oct 2024.
  • Avid Bioservices, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the quarter ending 31 Oct 2024 was $17,406,000, a 46% decline year-over-year.
  • Avid Bioservices, Inc. Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for the twelve months ending 31 Oct 2024 was $35,228,000, a 204% decline year-over-year.
  • Avid Bioservices, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2023 was $26,927,000, a 1794% decline from 2022.
  • Avid Bioservices, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2022 was $1,590,000, a 87% decline from 2021.
  • Avid Bioservices, Inc. annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest for 2021 was $12,661,000, a 13% increase from 2020.
Source SEC data
View on sec.gov
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Trailing 12 Months (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Quarterly (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Quarterly Change (%)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, Annual (USD)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest, YoY Annual Change (%)

Avid Bioservices, Inc. Quarterly Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2024 $35,228,000 $17,406,000 -$5,497,000 -46% 01 Aug 2024 31 Oct 2024 10-Q 10 Dec 2024 2025 Q2
Q2 2024 $29,731,000 $5,534,000 -$2,804,000 -103% 01 May 2024 31 Jul 2024 10-Q 09 Sep 2024 2025 Q1
Q1 2024 $26,927,000 $5,230,000 -$5,778,000 -1054% 01 Feb 2024 30 Apr 2024 10-K 02 Jul 2024 2024 FY
Q4 2023 $21,149,000 $7,058,000 -$9,572,000 -381% 01 Nov 2023 31 Jan 2024 10-Q 24 Apr 2024 2024 Q3
Q3 2023 $11,577,000 $11,909,000 -$8,493,000 -249% 01 Aug 2023 31 Oct 2023 10-Q 10 Dec 2024 2025 Q2
Q2 2023 $3,084,000 $2,730,000 -$4,674,000 -240% 01 May 2023 31 Jul 2023 10-Q 09 Sep 2024 2025 Q1
Q1 2023 $1,590,000 $548,000 -$39,000 -6.6% 01 Feb 2023 30 Apr 2023 10-K 02 Jul 2024 2024 FY
Q4 2022 $1,629,000 $2,514,000 +$266,000 +12% 01 Nov 2022 31 Jan 2023 10-Q 24 Apr 2024 2024 Q3
Q3 2022 $1,363,000 $3,416,000 -$6,938,000 -197% 01 Aug 2022 31 Oct 2022 10-Q/A 24 Apr 2024 2024 Q2
Q2 2022 $8,301,000 $1,944,000 -$4,360,000 -69% 01 May 2022 31 Jul 2022 10-Q/A 24 Apr 2024 2024 Q1
Q1 2022 $12,661,000 $587,000 01 Feb 2022 30 Apr 2022 10-K 02 Jul 2024 2024 FY
Q4 2021 $2,248,000 01 Nov 2021 31 Jan 2022 10-Q 13 Mar 2023 2023 Q3
Q3 2021 $3,522,000 01 Aug 2021 31 Oct 2021 10-Q 06 Dec 2022 2022 Q2
Q2 2021 $6,304,000 01 May 2021 31 Jul 2021 10-Q 06 Sep 2022 2023 Q1
Q4 2019 $2,104,000 -$921,000 -78% 01 Nov 2019 31 Jan 2020 10-Q 10 Mar 2020 2020 Q3
Q3 2019 $430,000 +$1,933,000 +82% 01 Aug 2019 31 Oct 2019 10-Q 09 Dec 2019 2020 Q2
Q1 2019 $5,340,000 $167,000 +$6,301,000 01 Feb 2019 30 Apr 2019 10-K 29 Jun 2021 2021 FY
Q4 2018 $11,641,000 $1,183,000 +$7,745,000 +87% 01 Nov 2018 31 Jan 2019 10-Q 10 Mar 2020 2020 Q3
Q3 2018 $19,386,000 $2,363,000 +$5,938,000 +72% 01 Aug 2018 31 Oct 2018 10-Q 09 Dec 2019 2020 Q2
Q2 2018 $25,324,000 $1,961,000 -$4,761,000 -170% 01 May 2018 31 Jul 2018 10-Q 10 Sep 2018 2019 Q1
Q1 2018 $20,563,000 $6,134,000 01 Feb 2018 30 Apr 2018 10-K 30 Jun 2020 2020 FY
Q4 2017 $8,928,000 -$7,359,000 -469% 01 Nov 2017 31 Jan 2018 10-Q 11 Mar 2019 2019 Q3
Q3 2017 $8,301,000 01 Aug 2017 31 Oct 2017 10-Q 10 Dec 2018 2019 Q2
Q2 2017 $2,800,000 01 May 2017 31 Jul 2017 10-Q 10 Sep 2018 2019 Q1
Q4 2016 $1,569,000 01 Nov 2016 31 Jan 2017 10-Q 12 Mar 2018 2018 Q3

Avid Bioservices, Inc. Annual Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $26,927,000 -$28,517,000 -1794% 01 May 2023 30 Apr 2024 10-K 02 Jul 2024 2024 FY
2022 $1,590,000 -$11,071,000 -87% 01 May 2022 30 Apr 2023 10-K 02 Jul 2024 2024 FY
2021 $12,661,000 +$1,449,000 +13% 01 May 2021 30 Apr 2022 10-K 02 Jul 2024 2024 FY
2020 $11,212,000 +$21,678,000 01 May 2020 30 Apr 2021 10-K/A 24 Apr 2024 2023 FY
2019 $10,466,000 -$5,126,000 -96% 01 May 2019 30 Apr 2020 10-K 29 Jun 2022 2022 FY
2018 $5,340,000 +$15,223,000 +74% 01 May 2018 30 Apr 2019 10-K 29 Jun 2021 2021 FY
2017 $20,563,000 -$21,956,000 -1576% 01 May 2017 30 Apr 2018 10-K 30 Jun 2020 2020 FY
2016 $1,393,000 -$2,204,000 -61% 01 May 2016 30 Apr 2017 10-K 27 Jun 2019 2019 FY
2015 $3,597,000 01 May 2015 30 Apr 2016 10-K 16 Jul 2018 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.